| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ENTA | ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Jun 17, 2024 | Sale | $12.33 | 7,266 | 89,590 | 32,341 | Jun 17, 2024, 08:38 PM | |
| ENTA | ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Feb 12, 2024 | Option Exercise | $12.41 | 973 | 12,075 | 39,607 | Feb 14, 2024, 08:21 PM | |
| ENTA | ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Sr. VP, New Prod. Strat. & Dev | Dec 05, 2023 | Sale | $9.63 | 2,125 | 20,464 | 37,260 | Dec 06, 2023, 08:29 PM | |
| ENTA | ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Sr. VP, New Prod. Strat. & Dev | Dec 01, 2023 | Option Exercise | $9.49 | 753 | 7,146 | 39,385 | Dec 05, 2023, 09:21 PM | |
| ENTA | ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Sr. VP, New Product Dev. | Feb 13, 2023 | Option Exercise | $52.77 | 6,725 | 354,878 | 40,138 | Feb 15, 2023, 09:51 PM | |
| ENTA | ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Sr. VP, New Product Dev. | Dec 01, 2022 | Option Exercise | $44.33 | 498 | 22,076 | 25,866 | Dec 05, 2022, 07:27 PM | |
| ENTA | ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Sr. VP, New Product Dev. | Feb 14, 2022 | Option Exercise | $62.49 | 552 | 34,494 | 7,864 | Feb 15, 2022, 09:51 PM |
Menu